Related Experiment Video

Updated: Aug 6, 2026

Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy
07:20

Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy

Published on: August 9, 2024

The use of botulinum toxin therapy for lower-extremity spasticity in children with cerebral palsy

Susan R Criswell1, Beth E Crowner, Brad A Racette

  • 1American Parkinson Disease Association Advanced Center for Parkinson Research, St. Louis, Missouri, USA.

Neurosurgical Focus
|August 22, 2006
PubMed

Insights

Botulinum toxin A injections help manage lower-extremity hypertonicity in children with cerebral palsy (CP). A multidisciplinary approach with these injections improves muscle tone and function.

Area of Science:

  • Pediatric Neurology
  • Rehabilitation Medicine
  • Biologics and Drug Therapy

Background:

  • Lower-extremity hypertonicity is a significant cause of disability in children with cerebral palsy (CP).
  • Botulinum toxin A (BTA) is a widely used therapeutic agent for managing focal muscle spasticity due to its safety and efficacy.
  • Previous research indicates BTA injections improve range of motion and functional outcomes in select pediatric CP populations.

Purpose of the Study:

  • To present treatment algorithms for optimizing the use of Botulinum toxin A (BTA) in children with lower-extremity hypertonicity due to cerebral palsy (CP).
  • To provide detailed dosing and technical information to guide clinicians in BTA application.
  • To emphasize the critical role of a multidisciplinary team in managing CP-related lower-extremity tone.

Main Methods:

  • Review of randomized controlled trials and clinical studies on BTA efficacy in pediatric CP.
  • Development of evidence-based treatment algorithms tailored to clinical presentation.
  • Inclusion of detailed BTA dosing and injection technique recommendations.

Main Results:

  • BTA injections in specific muscle groups (ankle flexors, hamstrings, adductors) effectively reduce spasticity.
  • Improvements in passive and active range of motion are consistently observed post-injection.
  • Enhanced gait and functional outcomes are achievable in appropriately selected pediatric patients.

Conclusions:

  • Botulinum toxin A is a valuable tool for managing lower-extremity hypertonicity in children with CP.
  • A comprehensive, multidisciplinary approach is essential for maximizing treatment benefits.
  • Optimized BTA treatment, guided by proposed algorithms, can lead to significant improvements in muscle tone and overall function.

More Related Videos

Enhancing the Development and Growth of Infant Cerebral Palsy Rats Using Selective Spinal Manipulations05:04

Enhancing the Development and Growth of Infant Cerebral Palsy Rats Using Selective Spinal Manipulations

Published on: February 2, 2024

Abdominal Massage to Improve Motor Dysfunction in Rats with Cerebral Palsy08:24

Abdominal Massage to Improve Motor Dysfunction in Rats with Cerebral Palsy

Published on: August 11, 2023

Related Concept Videos

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Botulism01:22

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...